Association of antiretroviral therapy with fibrinogen levels in HIV-infection

University of California, San Francisco, San Francisco, California, United States
AIDS (London, England) (Impact Factor: 5.55). 03/2008; 22(6):707-15. DOI: 10.1097/QAD.0b013e3282f560d9
Source: PubMed


HIV infection is associated with an increased risk of coronary artery disease, but the contribution of inflammation versus antiretroviral drugs is not well understood. Fibrinogen is an inflammatory factor associated with atherosclerosis.
A total of 1131 HIV-infected patients and 281 controls [from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a population-based study of cardiovascular risk assessment] in the Study of Fat Redistribution and Metabolic Change in HIV infection (FRAM) had plasma fibrinogen levels measured. Multivariable linear regression identified factors associated with fibrinogen.
HIV-infected patients had higher levels of fibrinogen compared with controls (males: 25 mg/dl higher, P = 0.006; females: 21 mg/dl higher, P = 0.39). Among HIV-infected persons, median levels of fibrinogen were 11% higher in patients currently using any protease inhibitor (PI) compared with those not using a PI (P < 0.0001). The strongest univariate associations were with the individual PIs, ritonavir and indinavir. Patients taking indinavir boosted with ritonavir had median fibrinogen levels 8% higher than those on indinavir alone (P = 0.049). Lower levels of fibrinogen were seen in those HIV-infected patients currently using any nonnucleoside reverse transcriptase inhibitor (NNRTI) compared to those not using an NNRTI (nevirapine -14.4%, P < 0.0001; efavirenz -7%, P = 0.0002). The associations of ritonavir, indinavir, efavirenz and nevirapine with fibrinogen levels persisted after multivariable analysis and were independent of other antiretroviral use.
Protease inhibitor use is associated with elevated fibrinogen levels which may contribute to increased risk of atherosclerosis in HIV-infected patients. Conversely, NNRTI use is associated with lower fibrinogen levels which may decrease risk of atherosclerosis.

Download full-text


Available from: Steven B Heymsfield, Dec 15, 2014
  • Source
    • "More interestingly, few investigations suggested that glycohemoglobin might affect plasma fibrinogen concentrations in both genders and circulating high-sensitivity C-reactive protein (hs-CRP) in man [10] [11]. It also has been reported that the patients with HIV infection or unstable CAD companied by persistent chlamydia pneumonia had a higher plasma fibrinogen levels [12] [13], and the higher fibrinogen levels could predict progression of coronary calcification, independent of traditional cardiovascular risk factors [14] [15]. Furthermore, the elevated fibrinogen concentration was independently associated with the risk of ischemic myocardial injury regardless of platelet reactivity by the VerifyNow assay in patients who received percutaneous coronary intervention (PCI) [16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Some studies have suggested a relation of plasma fibrinogen to the severity of coronary artery disease (CAD). However, whether plasma fibrinogen can predict the presence and severity of CAD in patients with diabetes mellitus has not been determined. Methods: A total of consecutive 373 diabetic patients with typical angina pectoris who received coronary angiography were enrolled and classified into three groups by tertiles of Gensini score (GS, low group <8; intermediate group 8~28; high group >28). The relationship between fibrinogen and GS was evaluated. Results: There were correlations of fibrinogen with hemoglobin A1c, C-reactive protein, and GS (r = 0.17, r = 0.52, and r = 0.21, resp.; all P < 0.001). Area under the receivers operating characteristic curve of fibrinogen was 0.62 (95% CI 0.56-0.68, P < 0.001) for predicting a high GS. Multivariate analysis suggested that plasma fibrinogen was an independent predictor of a high GS for diabetic patients (OR = 1.40, 95% CI 1.04-1.88, and P = 0.026) after adjusting for traditional risk factors of CAD. Conclusions: The present data indicated that plasma fibrinogen, a readily measurable systematic inflammatory marker, appeared to be an independent predictor for the severity of CAD in diabetic patients.
    Full-text · Article · Apr 2014 · Disease markers
  • Source
    • "As described previously [8], [9], CRP and fibrinogen were quantitatively measured in frozen sera and plasma, respectively (i.e., stored at −70 degrees Celsius and not previously thawed) at both the first and second FRAM examination using the BNII nephelometer from Dade Behring (Deerfield, IL) which utilizes a particle-enhanced immunonephelometric assay. The lower limit of detection for the ultrasensitive CRP assay used in FRAM was 0.16 mg/L. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Whether HIV viremia, particularly at low levels is associated with inflammation, increased coagulation, and all-cause mortality is unclear. The associations of HIV RNA level with C-reactive protein (CRP), fibrinogen, interleukin (IL)-6 and mortality were evaluated in 1116 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV infection. HIV RNA level was categorized as undetectable (i.e., "target not detected"), 1-19, 20-399, 400-9999, and ≥ 10,000 copies/ml. Covariates included demographics, lifestyle, adipose tissue, and HIV-related factors. HIV RNA level had little association with CRP. Categories of HIV RNA below 10,000 copies/ml had similar levels of IL-6 compared with an undetectable HIV RNA level, while HIV RNA ≥ 10,000 copies/ml was associated with 89% higher IL-6 (p<0.001). This association was attenuated by ~50% after adjustment for CD4+ cell count. Higher HIV RNA was associated with higher fibrinogen. Compared to an undetectable HIV RNA level, fibrinogen was 0.6%, 1.9%, 4.5%, 4.6%, and 9.4% higher across HIV RNA categories, respectively, and statistically significant at the highest level (p = 0.0002 for HIV RNA ≥ 10,000 copies/ml). Higher HIV RNA was associated with mortality during follow-up in unadjusted analysis, but showed little association after adjustment for CD4+ cell count and inflammation. HIV RNA ≥ 10,000 copies/ml was associated with higher IL-6 and fibrinogen, but lower levels of viremia appeared similar, and there was little association with CRP. The relationship of HIV RNA with IL-6 was strongly affected by CD4 cell depletion. After adjustment for CD4+ cell count and inflammation, viremia did not appear to be substantially associated with mortality risk over 5 years.
    Full-text · Article · Nov 2011 · PLoS ONE
  • Source
    • "The inflammatory events associated with HIV as well as hepatitis C virus (HCV) have been correlated with the increased risk of the proinflammatory disease of atherosclerosis (Eugenin et al., 2008; Madden et al., 2008; Melendez et al., 2008; Reingold et al., 2008). HIVinfected individuals have increased concentration of serum lipids, soluble ICAM-1, soluble VCAM-1, soluble receptor 2 for tumor necrosis factor-alpha (sTNFR2), fibrinogen, and pro-inflammatory cytokines (TNFα, IL-6, IL-1β) and chemokines (MIP1α, MIP1β, and RANTES) (Appay and Sauce, 2008; Madden et al., 2008; Melendez et al., 2008). Furthermore, HIV can invade lymphocytes by viral fusion with their chemokine receptors CCR5 and CXCR4 acting as co-receptors with CD4 or by endocytosis upon binding to CCR5, CXCR4, or CD4 (Eugenin et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: S-glutathionylation is a reversible post-translational modification that continues to gain eminence as a redox regulatory mechanism of protein activity and associated cellular functions. Many diverse cellular proteins such as transcription factors, adhesion molecules, enzymes, and cytokines are reported to undergo glutathionylation, although the functional impact has been less well characterized. De-glutathionylation is catalyzed specifically and efficiently by glutaredoxin (GRx, aka thioltransferase), and facile reversibility is critical in determining the physiological relevance of glutathionylation as a means of protein regulation. Thus, studies with cohesive themes addressing both the glutathionylation of proteins and the corresponding impact of GRx are especially useful in advancing understanding. Reactive oxygen species (ROS) and redox regulation are well accepted as playing a role in inflammatory processes, such as leukostasis and the destruction of foreign particles by macrophages. We discuss in this review the current implications of GRx and/or glutathionylation in the inflammatory response and in diseases associated with chronic inflammation, namely diabetes, atherosclerosis, inflammatory lung disease, cancer, and Alzheimer's disease, and in viral infections.
    Full-text · Article · Jun 2008 · Molecules and Cells
Show more